Company: MYGN
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0000899923-25-000048
Chunk: 60

Company: MYRIAD GENETICS INC
Filing Date: 2025-05-07
Form: 10-Q
Item: Part I, Item 8
Chunk 60
---
 of the assets or liabilities.  Some of the Company’s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.Level 3—unobservable inputs.The fair value of the Company’s long-term debt, which it considers a Level 2 measurement, is estimated using a discounted cash flow analysis based on the Company’s current estimated incremental borrowing rates for similar borrowing arrangements. The fair value of the Company’s long-term debt is estimated to be $59.7 million at March 31, 2025.

10

Table of Contents

4.PROPERTY, PLANT, AND EQUIPMENT, NET

The property, plant, and equipment at March 31, 2025 and December 31, 2024 were as follows:(in millions)March 31,2025December 31,2024Leasehold improvements$78.8 $78.5 Equipment118.7 148.5 Property, plant, and equipment, gross197.5 227.0 Less accumulated depreciation(83.5)(109.6)Property, plant, and equipment, net$114.0 $117.4 The Company recorded depreciation during the respective periods as follows:Three months endedMarch 31,(in millions)20252024Depreciation expense$5.1 $4.9 

5.    GOODWILL AND INTANGIBLE ASSETS

GoodwillAs of March 31, 2025, there were no changes in the carrying amount of goodwill and no impairment losses were recognized during the period.Intangible AssetsThe following tables summarize the amounts reported as intangible assets:(in millions)GrossCarryingAmountAccumulatedAmortizationNetAt March 31, 2025Developed technologies$559.4 $(335.5)$223.9 Internal-use software2.8 (0.9)1.9 Customer relationships1.6 (0.4)1.2 Trademarks6.1 (1.5)4.6 Licensed technologies2.8 (0.1)2.7 Internal-use software (in-process)23.2 — 23.2 Total intangible assets$595.9 $(338.4)$257.5 (in millions)GrossCarryingAmountAccumulatedAmortizationNetAt December 31, 2024Developed technologies$560.1 $(326.5)$233.